Enjaymo
sutimlimab-jome
Listed by Recordati Rare Diseases, Inc.
- Strength
- 50 mg/mL
- Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Class
- Classical Complement Pathway Inhibitor
What it contains
- Sutimlimab 50 mg/mL
FDA record
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Classical Complement Pathway Inhibitor |
| Approval route | BLA — biologic licence |
| NDC code | 55292-820 |
| FDA application | BLA761164 |
| RxNorm concept | 2591419 |
| Package sizes listed | 1 |
| Marketed since | February 2022 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.